Anne-Marie Mes-Masson Appointed to the CRCHUM’s Management Team

Version imprimable
December 1, 2017
Anne-Marie Mes-Masson

The University of Montreal Hospital Research Centre (CRCHUM) has announced the appointment of Anne-Marie Mes-Masson as Associate Scientific Director of Basic and Translational Research.

A leading cancer researcher, Anne-Marie Mes-Masson has directed the CRCHUM’s Cancer Research Theme since 2001. She is a Full Professor at the Université de Montréal’s Faculty of Medicine, Scientific Director of the Institut de Cancer de Montréal, and Director of the FRSQ Cancer Research Network. 

In her new position, Anne-Marie Mes-Masson’s mandate will be to foster the development of basic and translational research activities at the CHUM, in relation with clinical and population health research, as part of the research continuum. She starts her new position today, December 1st, replacing Dr. Michel Roger

“I would like to offer sincere thanks to Michel Roger for his hard work over the past two years. Michel’s achievements include structuring of the core facilities, developing centralized biobanks and establishing the facilities management committee,” stated Dr. Vincent Poitout, Director of Research at the CHUM and Director of the CRCHUM.

Anne-Marie Mes-Masson will work closely with the other members of the management team to establish the CRCHUM’s scientific development plan, in order to support research projects, infrastructure development and the recruitment and career advancement of our researchers, while ensuring excellence in basic and translational research. 

“I am enthusiastic about undertaking this new mandate, and am keen to contribute my strategic planning expertise, with a view to sharing ideas with the management team. Together, we will take on challenges and seize the scientific development opportunities that come our way,” declared Anne-Marie Mes-Masson.

Anne-Marie Mes-Masson – biography

After completing her doctorate at McGill University, Anne-Marie Mes-Masson undertook a postdoctoral fellowship in California, followed by a three-year assignment at the Biotechnology Research Institute. In 1989, she joined the Université de Montréal, teaching at the Faculty of Medicine and conducting research at the University of Montreal Hospital Research Centre (CRCHUM). She is currently the director of the CRCHUM’s Cancer Research Theme, the scientific director of the Institut du Cancer de Montréal, the director of the FRSQ Cancer Research Network and the coordinator of the Quebec Node of the Terry Fox Research Institute. A pioneer in the field of human tissue biobanks for research purposes, she directs several cancer research programs. Her research work contributes to the development of new clinical tools for diagnosing, managing and treating ovarian cancer.